Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Venom Gets Good Buzz as Potential Cancer Drug

August 11, 2014 10:16 am | News | Comments

Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs, reported scientists who have devised a method for targeting venom proteins specifically to malignant cells while sparing healthy ones. Read more...

TOPICS:

Ethical Questions Emerge Over Who Gets Ebola Drug

August 11, 2014 10:00 am | by Ciaran Giles, Maria Cheng, Associated Press | News | Comments

In a development that raises a host of ethical issues, Spain announced it had obtained a scarce U.S.-made experimental Ebola drug to treat a Spanish missionary priest infected with the killer virus, despite the U.S. Centers for Disease Control and Prevention having said there were virtually no doses available of the drug. Read more...

TOPICS:

Results Show Anthrax Vaccine is Potent with Rapid Onset

August 8, 2014 3:25 pm | News | Comments

Soligenix Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax. Read more...

TOPICS:
Advertisement

Genentech Submits sBLA for Diabetic Retinopathy Drug

August 8, 2014 3:21 pm | News | Comments

Genentech, a member of the Roche Group, announced that the company has submitted a supplemental Biologics License Application for Lucentis (ranibizumab injection) to the U.S. Food and Drug Administration for the treatment of diabetic retinopathy. Read more...

TOPICS:

New Culprit Identified in Metabolic Syndrome

August 8, 2014 3:11 pm | by Julia Evangelou Strait | News | Comments

A new study suggests uric acid - a normal waste product removed from the body by the kidneys and intestines and released in urine and stool - may play a role in causing metabolic syndrome, a cluster of risk factors that increases the risk of heart disease and type 2 diabetes. Read more...

TOPICS:

Neurovance Completes Enrollment in Abuse Liability Study

August 8, 2014 3:05 pm | News | Comments

Neurovance Inc. announced that it has completed enrollment in a human abuse liability study of centanafadine (formerly EB-1020), a novel non-stimulant being developed for the treatment of adults with attention deficit hyperactivity disorder (ADHD). Read more...

TOPICS:

Discovery IDs a New Class of Antibiotics

August 8, 2014 3:00 pm | News | Comments

St. Jude Children's Research Hospital scientists have discovered an enzyme -  fatty acid kinase - that regulates production of the toxins that contribute to potentially life-threatening Staphylococcus aureus infections. Read more...

TOPICS:

WHO Declares Ebola Outbreak an International Public Health Emergency

August 8, 2014 2:47 pm | by Maria Cheng, AP Medical Writer | News | Comments

The World Health Organization urged nations worldwide Friday to donate money and resources to stop the spread of Ebola as it declared the outbreak in West Africa to be an international public health emergency, having so far killed at least 961 people. Read more...

TOPICS:
Advertisement

Breaking News: China Jails British-US Investigator Couple

August 8, 2014 1:50 pm | News | Comments

A Briton and an American were sentenced to prison on Friday on charges of illegally trading in the personal details of Chinese citizens after they testified they bought such information to help companies combat fraud and acknowledged having obtained personal details about Chinese nationals. Read more...

TOPICS:

3SBio, DiNonA Partner on Leukemia mAb

August 8, 2014 10:46 am | News | Comments

3SBio Inc. announced it has entered into an exclusive license with DiNonA Inc. for the development, manufacturing and marketing of Leukotuximab, an anti JL-1 antibody for acute leukemia, including acute myelocytic leukemia and acute lymphoblastic leukemia, in the territory of Greater China and the Middle East. Read more...

TOPICS:

EMA Accepts Application for New Pneumococcal Vaccine Indication

August 8, 2014 10:41 am | News | Comments

Pfizer Inc. announced that the European Medicines Agency has accepted Pfizer’s application seeking to expand the indication for Prevenar 13 in adults to include the prevention of pneumonia caused by the 13 pneumococcal serotypes contained in the vaccine. Read more...

TOPICS:

Charity, Industry Join Forces on Pancreatic Cancer Drugs

August 8, 2014 10:35 am | News | Comments

Cancer Research UK and its commercial arm, Cancer Research Technology, are to join forces with Astellas Pharma Inc. to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer, one of the deadliest forms of cancer. Read more...

TOPICS:

British, US Couple Testify in Chinese Trial

August 8, 2014 10:28 am | News | Comments

A Briton and an American charged with illegally trading in the personal details of Chinese nationals testified Friday that they bought such information to help companies combat fraud under contract for British pharmaceutical giant GlaxoSmithKline, which is accused in a separate case of bribing Chinese doctors and hospitals to use its products. Read more...

TOPICS:

Splicing Modifiers May Correct Spinal Muscular Atrophy Deficit

August 8, 2014 10:03 am | News | Comments

The journal Science published results of a preclinical study demonstrating that treatment with orally available RNA splicing modifiers of the SMN2 gene starting early after birth is preventing deficits in mouse models of Spinal Muscular Atrophy. Read more...

TOPICS:

FDA Lifts Hold on Tekmira’s Experimental Ebola Drug

August 8, 2014 9:55 am | by Matthew Perrone, AP Health Writer | News | Comments

U.S. health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus, prompting praise by Tekmira's CEO Mark Murray on Thursday. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading